SME
IPO ·
NSE SME
ABH Healthcare Ltd
Listed
Incorporated in 2021, ABH Healthcare Ltd provides healthcare services, operates under the name "Anil Baghi Hospital".
Issue details
Price band
₹96 – ₹102
Face value
₹10
Lot size
1,200 shares
Minimum investment
₹2,44,800
Issue size
₹34.98 Cr
Fresh issue
₹33.22 Cr
Offer for sale
—
Issue type
Book Built
Exchange
NSE SME
Key dates
Opens
24 Aug 2026
Closes
27 Aug 2026
UPI mandate cut-off
5:00 PM on 27 Aug 2026
Allotment
28 Aug 2026
Refunds
31 Aug 2026
Shares in demat
31 Aug 2026
Listing
1 Sep 2026
Subscription and listing
Subscription
1.41x
Listing price
₹99
Registrar
Bigshare Services Pvt Ltd
Lead manager
Fedex Securities
Subscription by category
Total
1.41x
Total applications
1,116
Listing day
Issue price
₹102
Open
₹99.00
High
₹99.00
Low
₹94.05
Day close
₹94.05
Listing gain at open
-2.94%
Issue structure
Shares reserved per category and share of the total issue
QIB
1,99,200
5.81%
NII
15,28,800
44.58%
bNII > ₹10L
10,18,800
29.71%
sNII < ₹10L
5,10,000
14.87%
Retail
15,28,800
44.58%
Market Maker
1,72,800
5.04%
Total
34,29,600
100.00%
Finaccle’s quick read
Avoid
FY26 income up 7%, PAT up 5%, ROE 39.07%, D/E 3.20, post-issue P/E 20.69x.
A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.
About the company
Incorporated in 2021, ABH Healthcare Ltd provides healthcare services, operates under the name "Anil Baghi Hospital". The company has 150 beds and offer 25 medical specialities, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc. The hospital has empaneled with 30 private and public health insurance providers and third-party administrators.
Founded
Promoters
Promoter holding
Financial performance
Period
PAT
ROE
39.07%
ROCE
19.09%
Debt / equity
3.20
PAT margin
10.74%
P/E post issue
20.69
Market cap
₹116.58 Cr
Use of IPO money
Repayment / prepayment, in part or full, of certain of borrowings
₹17.00 Cr
Funding working capital requirements
₹5.00 Cr
Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as Objects)
₹8.62 Cr
Issue Expenses
₹4.36 Cr
Strengths
✓
PAT margin of 10.74%
✓
ROE of 39.07% and ROCE of 19.09%
Risks to watch
!
High leverage: debt to equity 3.20
!
SME platform: large lot size and thinner trading liquidity
Planning to take your own company public?
Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.
Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.
Last updated:
Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.